Medical Blog About Treatment Abroad

Cancer of the bowel can seem overwhelming initially, but learning about your diagnosis is a great first step toward feeling more in control of your health. Also known as colon cancer, it is a malignant growth in the large intestine, including the colon and rectum. It makes up about 7.6% of all new malignancy diagnoses in the USA...

Anal carcinoma is a rare but increasingly common, malignant neoplasm: the incidence has increased by approximately 2.7% per year over the past decade. Squamous cell carcinoma (SCC) accounts for about 85% of all cases, and a significant part of the diagnoses is HPV-positive anal squamous cell carcinoma. Although this type...

Glioblastoma (GBM) is the most common primary malignant tumor of the brain and accounts for about 16% of all primary neoplasms of the brain and central nervous system. The average age-standardized incidence rate is estimated at 3.2 cases per 100,000 population. As one of the most aggressive forms of brain cancer, glioblastoma...

In recent years, medical tourism has been on the rise worldwide, and Germany stands out as one of the most trusted destinations for medical treatment. Boasting cutting-edge medical technology, high-quality medical care, and professional healthcare providers, the country has become a top choice for foreign patients seeking complex medical...

The Rafaelo® procedure is a modern, minimally invasive method of hemorrhoid treatment in Germany with high performance indicators. It is based on the use of radiofrequency energy, which delicately reduces the volume of hemorrhoidal tissue. The method is optimal for patients with internal hemorrhoids of the II-III degree, providing...

Stage 4 stomach cancer is diagnosed in approximately 30,300 Americans annually, which is 1.5% of all cancers. The highest risk is for people over 55. This type of oncology presents serious challenges, but newer treatments in advanced medical centers improve outcomes. Modern therapies – like HIPEC, PIPAC, and dendritic cell vaccines...

The reality drives the urgent need for novel and more effective astrocytoma treatments. Astrocytoma group of neoplasms includes relatively slow-growing grades I–III and grade IV – glioblastoma, mentioned among the most lethal cancers. In the U.S., gliomas strike roughly 6 per 100,000 people annually. That is, each year, about 25,400...

One in eight men will develop prostate cancer during their lifetime. In 2025 alone, approximately 314,000 new cases are expected. And yet – mortality from this disease has dropped 50% since 1993. More than 3.5 million diagnosed men are alive today. Only one in 44 will die from prostate cancer when they receive proper medical care.